• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Newsletters » BioWorld Science

BioWorld Science

July 24, 2006

View Archived Issues

Fluoglizine more potent than fluoxetine in a mouse model of depression/anxiety

Read More

Neuroprotective effects of RWJ-333369 shown in a rat status epilepticus model

Read More

Emisphere and Roche establish multiproduct research collaboration

Read More

Inex to complete spin-out of Tekmira in September

Read More

Russian sites cleared to participate in BiovaxID phase III study

Read More

Xceleron to conduct phase 0 microdose study for Biofrontera Bioscience

Read More

Nerviano Medical Sciences to scale up Indena compounds

Read More

DNAPrint Genomics signs research agreement with Beth Israel Deaconess

Read More

DAC selects Evotec as partner for Hsp90 discovery project

Read More

ProtoKinetix' AAGP protects cells while preserving normal cell function

Read More

Alteon shareholders approve HaptoGuard merger

Read More

ImClone and Merck amend and supplement Erbitux agreement

Read More

New phase II study evaluates HGS-ETR1 with bortezomib in multiple myeloma

Read More

AVI BioPharma modifies HCV study of AVI-4065

Read More

CF-101 begins phase IIb for rheumatoid arthritis

Read More

CellTran and Innogenetics negotiate combining wound care activities

Read More

Nikken Chemical launches Selenica R tablet 400 mg in Japan

Read More

New glia-targeting clinical candidate presented with efficacy in AD

Read More

Nexavar approved in Europe for advanced renal cell carcinoma

Read More

New agents for treating neurological disorders disclosed in recent patent literature

Read More

Novel therapeutic agents for metabolic disorders reported

Read More

Symbicort receives FDA approval

Read More

New TGF-beta antagonists prepared and tested by Korean scientists

Read More

Tysabri available in U.S. for relapsing MS

Read More

TaiGen Biotechnology reports initial preclinical data of its novel agent against SARS virus

Read More

Tygacil now available in U.K.

Read More

Lansoprazole in chronic postnasal drip to be evaluated in clinical study / News in Context

Read More

Important antinociceptive actions of PPC-5383, a novel acid-sensing ion channel blocker

Read More

Promising preclinical results of novel Abeta fibril-disrupting agents developed at ProteoTech

Read More

Protective effects of dactylorhin B against beta amyloid-induced brain mitochondrial toxicity

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 6, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 6, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 3, 2025
  • Cancer cell in the cross-hairs

    Pan-cancer proteome atlas reveals new biomarkers and targets

    BioWorld Science
    An international group of scientists has completed the first draft of The Pan-Cancer Proteome Atlas (TPCPA). The project is based on mass spectrometry of 22...
  • Biotech deal illustration

    City hits the town with $1B-plus deal with Biogen

    BioWorld
    A development deal with Biogen Inc. could eventually bring City Therapeutics Inc. about $1 billion in milestone payments. It’s a step in the direction the company...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe